|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/55 | |
| A61K 9/22 | |||
| A61K 9/26 | |||
| A61K 9/16 | |||
| A61K 47/20 | |||
| A61K 47/14 | |||
| A61K 47/12 | |||
| A61K 9/48 | |||
| A61K 9/50 |
| (11) | Number of the document | 2359830 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10015293.3 |
| Date of filing the European patent application | 2007-04-13 | |
| (97) | Date of publication of the European application | 2011-08-24 |
| (45) | Date of publication and mention of the grant of the patent | 2012-09-19 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 794837 P | 2006-04-26 | US |
| (72) |
Bhatt, Padmanabh P., US
Kidane, Argaw, US
Edwards, Kevin, US
|
| (73) |
Supernus Pharmaceuticals, Inc.,
1550 East Gude Drive, Rockville, MD 20850,
US
|
| (54) | Controlled released preparations of oxcarbazepine having sigmoidal release profile |
| Controlled released preparations of oxcarbazepine having sigmoidal release profile |